The Discounted Cash Flow (DCF) valuation of Cellectis SA (ALCLS.PA) is (10.53) EUR. With the latest stock price at 3.10 EUR, the upside of Cellectis SA based on DCF is -439.1%.
Based on the latest price of 3.10 EUR and our DCF valuation, Cellectis SA (ALCLS.PA) is a sell. selling ALCLS.PA stocks now will result in a potential gain of 439.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 9.2% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (60.26) - (6.31) | (10.53) |
| Upside | -2040.6% - -303.3% | -439.1% |